Subclinical hyperthyroidism is a risk factor for poor functional outcome after ischemic stroke

Stroke

Volumn 44, Issue 5, 2013, Pages 1446-1448

  Wollenweber, Frank Arne ^a   Zietemann, Vera ^a   Gschwendtner, Andreas ^a   Opherk, Christian ^a   Dichgans, Martin ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Germany 3 Munich Cluster for Systems Neurology   (Germany)

Author keywords

acute ischemic stroke; functional outcome; subclinical thyroid dysfunction

Indexed keywords

CHOLESTEROL; THYROTROPIN;

ADULT; AGED; ARTICLE; BARTHEL INDEX; BLOOD SAMPLING; BODY MASS; BRAIN ISCHEMIA; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; EUTHYROIDISM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; RISK FACTOR; SAMPLING; SMOKING; SUBCLINICAL HYPERTHYROIDISM; SYMPTOM; THYROID DISEASE; THYROTROPIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; THYROTROPIN;

EID: 84876820577     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.000833     Document Type: Article

References (12)

1. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012;379:1142-1154.
2. Biondi B. Mechanisms in endocrinology: heart failure and thyroid dysfunction. Eur J Endocrinol. 2012;167:609-618.
3. Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B. Subclinical hyperthyroidism as a risk factor for atrial fbrillation. Am Heart J. 2001;142:838-842.
4. Dörr M, Empen K, Robinson DM, Wallaschofski H, Felix SB, Völzke H. The association of thyroid function with carotid artery plaque burden and strokes in a population-based sample from a previously iodine-defcient area. Eur J Endocrinol. 2008;159:145-152.
5. Akhoundi FH, Ghorbani A, Soltani A, Meysamie A. Favorable functional outcomes in acute ischemic stroke patients with subclinical hypo-thyroidism. Neurology. 2011;77:349-354.
6. Baek JH, Chung PW, Kim YB, Moon HS, Suh BC, Jin DK, et al. Favorable infuence of subclinical hypothyroidism on the functional outcomes in stroke patients. Endocr J. 2010;57:23-29.
7. Vogeser M, Weigand M, Fraunberger P, Fischer H, Cremer P. Evaluation of the ADVIA Centaur TSH-3 assay. Clin Chem Lab Med. 2000;38:331-334.
8. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, et al. Thyroid status, cardiovascular risk, and mortality in older adults. J Am Med Assoc. 2006;295:1033-1041.
9. Lees KR, Bath PM, Schellinger PD, Kerr DM, Fulton R, Hacke W, et al; European Stroke Organization Outcomes Working Group. Contemporary outcome measures in acute stroke research: choice of primary outcome measure. Stroke. 2012;43:1163-1170.
10. Lavados PM, Sacks C, Prina L, Escobar A, Tossi C, Araya F, et al. Incidence, case-fatality rate, and prognosis of ischaemic stroke subtypes in a predominantly Hispanic-Mestizo population in Iquique, Chile (PISCIS project): a community-based incidence study. Lancet Neurol. 2007;6:140-148.
11. Erem C. Blood coagulation, fbrinolytic activity and lipid profile in sub-clinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clin Endocrinol (Oxf). 2006;64:323-329.
12. López M, Varela L, Vázquez MJ, Rodríguez-Cuenca S, González CR, Velagapudi VR, et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med. 2010;16:1001-1008.